# Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients With High Risk Stable CHD

> **NCT04433052** · NA · RECRUITING · sponsor: **Tampere University** · enrollment: 12000 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **BEHAVIORAL:** personalised prevention program (PPP)

## Key facts

- **NCT ID:** NCT04433052
- **Lead sponsor:** Tampere University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 12000 (ESTIMATED)
- **Last updated:** 2023-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04433052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04433052, "Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients With High Risk Stable CHD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04433052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*